Ambazone

N/A

Report date: 2023/01/14 16:58:36

NME

Base Information

Drug NameAmbazone

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUndefined mechanism

TargetsNot applicable

Therapy Area/IndicationsLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBerlin Chemie

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBerlin Chemie

Active IndicationsN/A

Inactive IndicationsLeukemia

ATC CodeR02AA01